Nicotinamide Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Sales Channel (Direct, Indirect), By End Use (Pharmaceuticals, Cosmetics & Personal Care, Food & Beverages, Animal Feed, Chemicals), By Region & Competition, 2021-2031F

May 2026 | 180 pages | ID: NA9E594B5D10EN
TechSci Research

Abstracts

The global nicotinamide market is projected to expand significantly, rising from USD 717.21 million in 2025 to USD 1063.13 million by 2031, demonstrating a compound annual growth rate of 6.78%. Nicotinamide, a crucial water-soluble form of Vitamin B3, is widely incorporated into pharmaceutical products, cosmetic formulations, and animal nutrition. This market growth is primarily fueled by the increasing incidence of dermatological conditions that require effective skin barrier solutions, alongside the substantial growth of the global livestock industry's demand for high-performance feed additives for disease prevention. Additionally, a growing consumer focus on preventative healthcare significantly increases the industrial consumption of vitamin-based dietary supplements. However, the market faces considerable hurdles, particularly concerning supply chain instability and the concentrated nature of its manufacturing base. A strong dependence on specific regions for synthesizing raw materials makes the market susceptible to trade shifts and logistical delays, hindering consistent sourcing. For instance, the European Feed Manufacturers' Federation reported in 2025 that the European Union imported over 75% of its Vitamin B3, highlighting the substantial risks linked to centralized global production and potential disruptions for related industries.

Market Driver

The global nicotinamide market is undergoing a significant transformation driven by the escalating demand for cosmeceuticals and anti-aging skincare products, owing to the compound's recognized efficacy in improving skin barrier function and diminishing hyperpigmentation. Cosmetic companies are actively integrating high-purity Vitamin B3 into various serums and creams to satisfy a knowledgeable consumer base seeking versatile active ingredients. This trend is supported by substantial consumer engagement; a November 2025 Foundation report, 'New data reveals top skincare ingredients of 2024', identified Niacinamide as the fourth most searched skincare ingredient, affirming its crucial position in contemporary beauty routines alongside established compounds like retinol. This enduring popularity is prompting chemical suppliers to increase production of cosmetic-grade nicotinamide to fulfill the personal care sector's stringent purity standards. Concurrently, market growth is fueled by the expanding animal feed sector, propelled by global livestock production, where nicotinamide is a vital additive for enhancing metabolic health and preventing diseases in poultry and swine. With increasing global meat consumption, the industrial demand for feed-grade vitamins intensifies, crucial for ensuring peak herd performance and food security. The '2025 Agri-Food Outlook' by Alltech (November 2025) noted a 1.2% rise in global feed production in 2024, reaching 1.396 billion metric tons, which directly translates to greater Vitamin B3 procurement. Further underscoring this sector's strength, dsm-firmenich reported in February 2025 that their Animal Nutrition & Health unit achieved 5% organic sales growth in 2024, indicating strong commercial vibrancy within the livestock nutrition landscape.

Market Challenge

The global nicotinamide market encounters a major obstacle to its expansion stemming from the pronounced geographic centralization of its manufacturing operations. This profound dependence on a restricted number of regional production centers establishes a vulnerable supply chain structure, making it susceptible to widespread availability problems triggered by isolated local incidents like regulatory changes or logistical disruptions. As a result, downstream industries often experience significant price fluctuations and irregular raw material supplies, which impedes their capacity for long-term growth planning and destabilizes the consistent market evolution needed. The profound nature of this structural weakness is clearly demonstrated by recent trade statistics, which highlight the market's reliance on particular export sources. Data from the China Chamber of Commerce for Import & Export of Medicines & Health Products indicated that in 2024, China's total vitamin exports reached approximately USD 3.45 billion, with the U.S. market alone importing USD 840 million of this amount. This figure reveals a crucial bottleneck where global supply stability is intrinsically linked to the production capabilities of a single nation, thereby generating a risk landscape that discourages investment and introduces inefficiencies within the global distribution framework.

Market Trends

Manufacturers are progressively moving away from conventional chemical synthesis towards environmentally friendly biomanufacturing techniques, specifically employing chemo-enzymatic and microbial fermentation processes. This transition aims to reduce environmental impact and ensure adherence to regulatory standards. This strategic shift differs significantly from typical supply chain modifications, as its core objective is to minimize the carbon footprint of production to attract stakeholders focused on sustainability. Leading industry participants are formalizing these pledges with stringent validation frameworks, guaranteeing that their manufacturing innovations align with global climate benchmarks. For example, Lonza's 'Sustainability Report 2024' (April 2025) confirmed that its near-term greenhouse gas reduction targets were validated by the Science Based Targets Initiative in 2024, with a commitment to cut absolute Scope 1 and 2 emissions by 42% by 2030, thereby establishing a new standard for eco-efficient nicotinamide manufacturing. Concurrently, the market is experiencing a notable expansion into the male grooming segment, spurred by a demographic change where men are increasingly seeking functional skincare components such as Nicotinamide due to its non-greasy, barrier-reinforcing attributes. This trend is distinct from the wider cosmeceutical demand for general anti-aging formulations, as it specifically targets male consumers who leverage digital platforms to research ingredient effectiveness and product choices. This heightened engagement is reflected in social media search patterns indicating specific ingredient interest. A July 2025 'Men's Trends Report' by Cosmetics Business revealed a 35% increase in searches for niacinamide serum among male Pinterest users, underscoring the ingredient's growing prominence as a key component in men's personal care routines.

Key Market Players

• Nebula Health Care
• Suchem Laboratory
• Western Drugs Limited
• Roopa industries limited
• S.V. Labs Pvt. Ltd.
• Veer Chemie & Aromatics pvt ltd.
• Optimus Drugs Pvt. Ltd
• NIGAM FINECHEM PVT. LTD
• Ishita Drugs & Industries Ltd
• Anhui Redpont Biotechnology Co., Ltd

Report Scope

In this report, the Global Nicotinamide Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Nicotinamide Market, By Sales Channel
• Direct
• Indirect
• Nicotinamide Market, By End Use
• Pharmaceuticals
• Cosmetics & Personal Care
• Food & Beverages
• Animal Feed
• Chemicals
• Nicotinamide Market, By Region
• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Nicotinamide Market.

Available Customizations:

Global Nicotinamide Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Contents

1. PRODUCT OVERVIEW

1.1. Market Definition
1.2. Scope of the Market
  1.2.1. Markets Covered
  1.2.2. Years Considered for Study
  1.2.3. Key Market Segmentations

2. RESEARCH METHODOLOGY

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. EXECUTIVE SUMMARY

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. VOICE OF CUSTOMER

5. GLOBAL NICOTINAMIDE MARKET OUTLOOK

5.1. Market Size & Forecast
  5.1.1. By Value
5.2. Market Share & Forecast
  5.2.1. By Sales Channel (Direct, Indirect)
  5.2.2. By End Use (Pharmaceuticals, Cosmetics & Personal Care, Food & Beverages, Animal Feed, Chemicals)
  5.2.3. By Region
  5.2.4. By Company (2025)
5.3. Market Map

6. NORTH AMERICA NICOTINAMIDE MARKET OUTLOOK

6.1. Market Size & Forecast
  6.1.1. By Value
6.2. Market Share & Forecast
  6.2.1. By Sales Channel
  6.2.2. By End Use
  6.2.3. By Country
6.3. North America: Country Analysis
  6.3.1. United States Nicotinamide Market Outlook
    6.3.1.1. Market Size & Forecast
      6.3.1.1.1. By Value
    6.3.1.2. Market Share & Forecast
      6.3.1.2.1. By Sales Channel
      6.3.1.2.2. By End Use
  6.3.2. Canada Nicotinamide Market Outlook
    6.3.2.1. Market Size & Forecast
      6.3.2.1.1. By Value
    6.3.2.2. Market Share & Forecast
      6.3.2.2.1. By Sales Channel
      6.3.2.2.2. By End Use
  6.3.3. Mexico Nicotinamide Market Outlook
    6.3.3.1. Market Size & Forecast
      6.3.3.1.1. By Value
    6.3.3.2. Market Share & Forecast
      6.3.3.2.1. By Sales Channel
      6.3.3.2.2. By End Use

7. EUROPE NICOTINAMIDE MARKET OUTLOOK

7.1. Market Size & Forecast
  7.1.1. By Value
7.2. Market Share & Forecast
  7.2.1. By Sales Channel
  7.2.2. By End Use
  7.2.3. By Country
7.3. Europe: Country Analysis
  7.3.1. Germany Nicotinamide Market Outlook
    7.3.1.1. Market Size & Forecast
      7.3.1.1.1. By Value
    7.3.1.2. Market Share & Forecast
      7.3.1.2.1. By Sales Channel
      7.3.1.2.2. By End Use
  7.3.2. France Nicotinamide Market Outlook
    7.3.2.1. Market Size & Forecast
      7.3.2.1.1. By Value
    7.3.2.2. Market Share & Forecast
      7.3.2.2.1. By Sales Channel
      7.3.2.2.2. By End Use
  7.3.3. United Kingdom Nicotinamide Market Outlook
    7.3.3.1. Market Size & Forecast
      7.3.3.1.1. By Value
    7.3.3.2. Market Share & Forecast
      7.3.3.2.1. By Sales Channel
      7.3.3.2.2. By End Use
  7.3.4. Italy Nicotinamide Market Outlook
    7.3.4.1. Market Size & Forecast
      7.3.4.1.1. By Value
    7.3.4.2. Market Share & Forecast
      7.3.4.2.1. By Sales Channel
      7.3.4.2.2. By End Use
  7.3.5. Spain Nicotinamide Market Outlook
    7.3.5.1. Market Size & Forecast
      7.3.5.1.1. By Value
    7.3.5.2. Market Share & Forecast
      7.3.5.2.1. By Sales Channel
      7.3.5.2.2. By End Use

8. ASIA PACIFIC NICOTINAMIDE MARKET OUTLOOK

8.1. Market Size & Forecast
  8.1.1. By Value
8.2. Market Share & Forecast
  8.2.1. By Sales Channel
  8.2.2. By End Use
  8.2.3. By Country
8.3. Asia Pacific: Country Analysis
  8.3.1. China Nicotinamide Market Outlook
    8.3.1.1. Market Size & Forecast
      8.3.1.1.1. By Value
    8.3.1.2. Market Share & Forecast
      8.3.1.2.1. By Sales Channel
      8.3.1.2.2. By End Use
  8.3.2. India Nicotinamide Market Outlook
    8.3.2.1. Market Size & Forecast
      8.3.2.1.1. By Value
    8.3.2.2. Market Share & Forecast
      8.3.2.2.1. By Sales Channel
      8.3.2.2.2. By End Use
  8.3.3. Japan Nicotinamide Market Outlook
    8.3.3.1. Market Size & Forecast
      8.3.3.1.1. By Value
    8.3.3.2. Market Share & Forecast
      8.3.3.2.1. By Sales Channel
      8.3.3.2.2. By End Use
  8.3.4. South Korea Nicotinamide Market Outlook
    8.3.4.1. Market Size & Forecast
      8.3.4.1.1. By Value
    8.3.4.2. Market Share & Forecast
      8.3.4.2.1. By Sales Channel
      8.3.4.2.2. By End Use
  8.3.5. Australia Nicotinamide Market Outlook
    8.3.5.1. Market Size & Forecast
      8.3.5.1.1. By Value
    8.3.5.2. Market Share & Forecast
      8.3.5.2.1. By Sales Channel
      8.3.5.2.2. By End Use

9. MIDDLE EAST & AFRICA NICOTINAMIDE MARKET OUTLOOK

9.1. Market Size & Forecast
  9.1.1. By Value
9.2. Market Share & Forecast
  9.2.1. By Sales Channel
  9.2.2. By End Use
  9.2.3. By Country
9.3. Middle East & Africa: Country Analysis
  9.3.1. Saudi Arabia Nicotinamide Market Outlook
    9.3.1.1. Market Size & Forecast
      9.3.1.1.1. By Value
    9.3.1.2. Market Share & Forecast
      9.3.1.2.1. By Sales Channel
      9.3.1.2.2. By End Use
  9.3.2. UAE Nicotinamide Market Outlook
    9.3.2.1. Market Size & Forecast
      9.3.2.1.1. By Value
    9.3.2.2. Market Share & Forecast
      9.3.2.2.1. By Sales Channel
      9.3.2.2.2. By End Use
  9.3.3. South Africa Nicotinamide Market Outlook
    9.3.3.1. Market Size & Forecast
      9.3.3.1.1. By Value
    9.3.3.2. Market Share & Forecast
      9.3.3.2.1. By Sales Channel
      9.3.3.2.2. By End Use

10. SOUTH AMERICA NICOTINAMIDE MARKET OUTLOOK

10.1. Market Size & Forecast
  10.1.1. By Value
10.2. Market Share & Forecast
  10.2.1. By Sales Channel
  10.2.2. By End Use
  10.2.3. By Country
10.3. South America: Country Analysis
  10.3.1. Brazil Nicotinamide Market Outlook
    10.3.1.1. Market Size & Forecast
      10.3.1.1.1. By Value
    10.3.1.2. Market Share & Forecast
      10.3.1.2.1. By Sales Channel
      10.3.1.2.2. By End Use
  10.3.2. Colombia Nicotinamide Market Outlook
    10.3.2.1. Market Size & Forecast
      10.3.2.1.1. By Value
    10.3.2.2. Market Share & Forecast
      10.3.2.2.1. By Sales Channel
      10.3.2.2.2. By End Use
  10.3.3. Argentina Nicotinamide Market Outlook
    10.3.3.1. Market Size & Forecast
      10.3.3.1.1. By Value
    10.3.3.2. Market Share & Forecast
      10.3.3.2.1. By Sales Channel
      10.3.3.2.2. By End Use

11. MARKET DYNAMICS

11.1. Drivers
11.2. Challenges

12. MARKET TRENDS & DEVELOPMENTS

12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments

13. GLOBAL NICOTINAMIDE MARKET: SWOT ANALYSIS

14. PORTER'S FIVE FORCES ANALYSIS

14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products

15. COMPETITIVE LANDSCAPE

15.1. Nebula Health Care
  15.1.1. Business Overview
  15.1.2. Products & Services
  15.1.3. Recent Developments
  15.1.4. Key Personnel
  15.1.5. SWOT Analysis
15.2. Suchem Laboratory
15.3. Western Drugs Limited
15.4. Roopa industries limited
15.5. S.V. Labs Pvt. Ltd.
15.6. Veer Chemie & Aromatics pvt ltd.
15.7. Optimus Drugs Pvt. Ltd
15.8. NIGAM FINECHEM PVT. LTD
15.9. Ishita Drugs & Industries Ltd
15.10. Anhui Redpont Biotechnology Co., Ltd

16. STRATEGIC RECOMMENDATIONS

17. ABOUT US & DISCLAIMER